#ESMO21 Expert Video Report on Prostate cancer

Published 2021-09-30

Recommendations

Similar videos

07:08

Expert video report on Prostate Cancer from 2021 Genitourinary Cancers Symposium
11:51

Expert Video Report on castration sensitive and resistant prostate cancer - 2021 ASCO Annual Meeting
06:03

#ESMO21 Expert Video Report on colorectal cancer
02:45

#ESMO21 Highlights on MFS analysis from comb. treatments in high-risk adv. prostate cancer: STAMPEDE
10:14

Expert Commentary: Gastrointestinal cancers and Prostate cancer at ESMO Congress 2021
07:25

#ESMO21 Expert Video Report on immunotherapy in gastro-oesophageal cancer
03:18

#ESMO21 Highlights on combination of pembrolizumab plus chemotherapy in mTNBC: The KEYNOTE-355 study
02:59

#ESMO21 Highlights on atezolizumab combined with FOLFOXIRI + bev in 1st-line mCRC: AtezoTRIBE study
02:18

#ESMO21 Highlights on maintenance olaparib in ovarian cancer previously treated with PARPi
02:26

#ESMO21 Highlights on pembro + chemo in 1st-line metastatic cervical cancer: The KEYNOTE-826 study
02:30

#ESMO21 Highlights on gemcitabine vs mFOLFIRINOX in resected pancreatic cancer: PRODIGE 24/CCTG PA6
01:41

#ESMO21 Highlights on nivolumab in pretreated thymoma & thymic carcinoma: EORTC-ETOP NIVOTHYM study
01:19

Breast cancer research at ESMO 2021
02:42

#ESMO21 Highlights on aspirin use in recurrent platinum-resistent ovarian cancer: EORTC-1508 study
01:35

#ESMO21 Highlights on a phase I of dual RAF/MEK inhibitor + FAK inhibitor in ovarian cancer (FRAME)
03:09

#ESMO21 Highlights on nivo+ipi vs EXTREME in 1st-line high-risk SCCHN: The CheckMate 651 study
01:56

Lung cancer research at ESMO 2021
02:51

#ESMO21 Highlights on adagrasib in patients with KRASG12C-mutated CRC: The KRYSTAL-1 study
02:47

#ESMO21 Highlights on erdafitinib in adv. urothelial cancer with FGFRa alterations: The NORSE study
More results